CCLD vs CLOV

For growth investors, Clover Health Investments, Corp.

(CLOV) is the stronger pick with 40. 3% revenue growth year-over-year, versus 8. 7% for CareCloud, Inc. (CCLD). CareCloud, Inc. (CCLD) offers the better valuation at 24. 9x trailing P/E (14. 2x forward), making it the more compelling value choice. Analysts rate CareCloud, Inc. (CCLD) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, CareCloud, Inc.

is actually cheaper at 14. 2x.

Over the past 5 years, Clover Health Investments, Corp.

(CLOV) delivered a total return of -67. 3%, compared to -69. 5% for CareCloud, Inc. (CCLD). Over 10 years, the gap is even starker: CCLD returned +155. 4% versus CLOV's -72. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), CareCloud, Inc.

(CCLD) is the lower-risk stock at 1. 15β versus Clover Health Investments, Corp. 's 1. 22β — meaning CLOV is approximately 7% more volatile than CCLD relative to the S&P 500.

By revenue growth (latest reported year), Clover Health Investments, Corp.

(CLOV) is pulling ahead at 40. 3% versus 8. 7% for CareCloud, Inc. (CCLD). On earnings-per-share growth, the picture is similar: CareCloud, Inc. grew EPS 135. 7% year-over-year, compared to -93. 6% for Clover Health Investments, Corp.. Over a 3-year CAGR, CLOV leads at 20. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

CareCloud, Inc.

(CCLD) is the more profitable company, earning 9. 0% net margin versus -4. 4% for Clover Health Investments, Corp. — meaning it keeps 9. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CCLD leads at 10. 1% versus -4. 4% for CLOV. At the gross margin level — before operating expenses — CCLD leads at 34. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, CareCloud, Inc.

(CCLD) trades at 14. 2x forward P/E versus 65. 9x for Clover Health Investments, Corp. — 51. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CCLD: 30. 8% to $3. 25.

In this comparison, CCLD (0.

7% yield) pays a dividend. CLOV does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, CareCloud, Inc.

(CCLD) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 15), 0. 7% yield, +155. 4% 10Y return). Both have compounded well over 10 years (CCLD: +155. 4%, CLOV: -72. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: CCLD is a small-cap quality compounder stock; CLOV is a small-cap high-growth stock. CCLD pays a dividend while CLOV does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.